Matches in Wikidata for { <http://www.wikidata.org/entity/Q91654066> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q91654066 description "article scientifique publié en 2019" @default.
- Q91654066 description "artículu científicu espublizáu en febreru de 2019" @default.
- Q91654066 description "scientific article published on 18 February 2019" @default.
- Q91654066 description "wetenschappelijk artikel" @default.
- Q91654066 description "наукова стаття, опублікована в лютому 2019" @default.
- Q91654066 name "Toxicity and efficacy of alemtuzumab combined with CHOP for aggressive T-cell lymphoma: a phase 1 dose-escalation trial" @default.
- Q91654066 name "Toxicity and efficacy of alemtuzumab combined with CHOP for aggressive T-cell lymphoma: a phase 1 dose-escalation trial" @default.
- Q91654066 type Item @default.
- Q91654066 label "Toxicity and efficacy of alemtuzumab combined with CHOP for aggressive T-cell lymphoma: a phase 1 dose-escalation trial" @default.
- Q91654066 label "Toxicity and efficacy of alemtuzumab combined with CHOP for aggressive T-cell lymphoma: a phase 1 dose-escalation trial" @default.
- Q91654066 prefLabel "Toxicity and efficacy of alemtuzumab combined with CHOP for aggressive T-cell lymphoma: a phase 1 dose-escalation trial" @default.
- Q91654066 prefLabel "Toxicity and efficacy of alemtuzumab combined with CHOP for aggressive T-cell lymphoma: a phase 1 dose-escalation trial" @default.
- Q91654066 P1433 Q91654066-D3516A73-C72D-4BCD-96DD-16F60197E8C0 @default.
- Q91654066 P1476 Q91654066-B0A047E5-6822-4C1C-8D40-24CC0EA68AB3 @default.
- Q91654066 P2093 Q91654066-0CFE9DCC-5046-4537-A0EE-3DD8F315201C @default.
- Q91654066 P2093 Q91654066-242CBC10-555D-4F7C-B30F-FCFADBEF8966 @default.
- Q91654066 P2093 Q91654066-38C9A8B6-F03B-404A-A243-57EB94D6F05D @default.
- Q91654066 P2093 Q91654066-4F048504-31D2-4952-86AF-5F3DC6238ECA @default.
- Q91654066 P2093 Q91654066-61E59D14-7C47-40FA-A3DE-19C77E45A4AA @default.
- Q91654066 P2093 Q91654066-D982678F-D4CE-404C-A5D2-7B95A7FFD98F @default.
- Q91654066 P304 Q91654066-CF16AFF2-ECF2-47D3-BC9D-D2788C845020 @default.
- Q91654066 P31 Q91654066-27F65D41-CAB2-4D16-9D14-FE1A590FACC1 @default.
- Q91654066 P356 Q91654066-0F7D15F7-6BE1-498E-A7E1-CAA7B5DEE018 @default.
- Q91654066 P433 Q91654066-95AF2E35-9FC0-41B6-866E-259A86D097CD @default.
- Q91654066 P478 Q91654066-53B4DE4A-8942-4209-9B0F-5F2160639076 @default.
- Q91654066 P50 Q91654066-B6DA5C8D-FB76-4DEB-8270-5528FC7BAF81 @default.
- Q91654066 P577 Q91654066-7A020B93-FDF6-40A3-A2FF-B2E473854496 @default.
- Q91654066 P698 Q91654066-1EE10E1F-A0FA-4FDE-A4B3-A261F2790A08 @default.
- Q91654066 P921 Q91654066-A0243228-6ED9-43A3-B570-1CF869C73010 @default.
- Q91654066 P356 10428194.2019.1576870 @default.
- Q91654066 P698 30773077 @default.
- Q91654066 P1433 Q6534493 @default.
- Q91654066 P1476 "Toxicity and efficacy of alemtuzumab combined with CHOP for aggressive T-cell lymphoma: a phase 1 dose-escalation trial" @default.
- Q91654066 P2093 "John Radford" @default.
- Q91654066 P2093 "Laura Clifton-Hadley" @default.
- Q91654066 P2093 "Naheed Mir" @default.
- Q91654066 P2093 "Rod Johnson" @default.
- Q91654066 P2093 "Stephen Devereux" @default.
- Q91654066 P2093 "Toyin Adedayo" @default.
- Q91654066 P304 "2291-2294" @default.
- Q91654066 P31 Q13442814 @default.
- Q91654066 P356 "10.1080/10428194.2019.1576870" @default.
- Q91654066 P433 "9" @default.
- Q91654066 P478 "60" @default.
- Q91654066 P50 Q61658729 @default.
- Q91654066 P577 "2019-02-18T00:00:00Z" @default.
- Q91654066 P698 "30773077" @default.
- Q91654066 P921 Q5452194 @default.